New Cochrane reviews confirm that HPV vaccines are highly effective at preventing cervical cancer and pre-cancerous changes. Protection works best when children are vaccinated early, ideally before age 16. Girls vaccinated at this age are about 80% less likely to develop cervical cancer. Side effects are usually minor, such as mild arm soreness. The National Institute for Health and Care Research (NIHR) supported the research, highlighting its global importance.
Understanding HPV and Cervical Cancer
Professor Emma Crosbie, a leading gynaecological oncologist at Manchester University, explained, “Cervical cancer is largely preventable. Vaccination and screening are key to saving lives.” HPV is a family of viruses. While many types are harmless, high-risk strains can cause cancers of the cervix, throat, anus, vulva, vagina, and penis. Other strains cause anogenital warts. Cervical cancer is the fourth most common cancer among women worldwide, causing over 300,000 deaths each year, mostly in low- and middle-income countries.
Clinical Trials Show Strong Evidence
The first Cochrane review analyzed 60 randomized trials involving over 157,000 participants. All vaccines reduced infections that could lead to cancer or other HPV-related conditions. Although HPV-related cancers take years to appear, vaccines already lower pre-cancerous changes and reduce treatments for people aged 15 to 25. Vaccines also decrease anogenital warts. Side effects were mostly mild, such as arm pain or swelling, while serious adverse events were extremely rare. Hanna Bergman, co-lead author, said, “The evidence shows HPV vaccines safely prevent infections that can cause cancer.”
Real-World Studies Confirm Long-Term Protection
The second review analyzed 225 studies covering more than 132 million people worldwide. Observational data confirms that HPV vaccination reduces cervical cancer and pre-cancerous lesions at a population level. Nicholas Henschke, co-lead author, emphasized, “There is no evidence linking HPV vaccines to serious health problems. Most side effects are minor and temporary.” Vaccination is most effective before exposure to HPV, reinforcing the importance of early immunization.
Global Impact and Future Steps
These reviews provide the most comprehensive evidence on HPV vaccination to date. They show that HPV vaccines are safe, highly effective, and capable of preventing hundreds of thousands of cancers annually. Experts recommend vaccinating both girls and boys ideally before age 16. More research is needed in low- and middle-income countries, where cervical cancer rates are high and screening programs are limited. Achieving the World Health Organization’s goal of eliminating cervical cancer will require high vaccination coverage, consistent screening, and timely treatment of pre-cancerous lesions.
About The Author
